Yes, but with a much larger royalty percentage to IPIX as IPIX will have assumed almost all of the risks and the BP is basically picking up the gravy train to the tune of possibly billions per year.

Whatever IPIX does after P2 increases the royalty rate. If we formulate the pill, do the work for the protocol for P3, etc that all goes into higher royalty rate. Once that is done, what is left for BP to do but strictly market a proven product?

I will qualify my reason to also include my age, which is advanced to most here, and I want/need to see the SP move upward very soon. If it is a couple of years out, that is a percentage of the time left for me I don't want to have forfeited.